EnVVeno Medical Corporation (NASDAQ:NVNO) | WebDisclosure

Switch to English

8295	Sociétés
114831	Mots-clés
55272	Articles
62429	Communiqués

Accueil
Sociétés
EnVVeno Medical Corporation

BRÈVE

publiée le 20/11/2024 à 14:35, il y a 20 heures 6 minutes

EnVVeno Medical dévoile les résultats de l'essai VenoValve sur un an

Essai Clinique Valve VenoValve Traitement CVI Demande D'admission À La FDA Résultats En Matière De Santé
BRÈVE

publiée le 20/11/2024 à 14:35, il y a 20 heures 6 minutes

EnVVeno Medical Unveils One-Year VenoValve Trial Results

Clinical Trial VenoValve Health Outcomes FDA Application CVI Treatment
COMMUNIQUÉ DE PRESSE

publié le 20/11/2024 à 14:30, il y a 20 heures 11 minutes

enVVeno Medical to Present Definitive One Year Data from the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH Symposium
enVVeno Medical presents one-year data on VenoValve U.S. pivotal trial at VEITH Symposium supporting FDA pre-market authorization application. Study shows significant clinical benefits and safety profile

EnVVeno Medical VenoValve FDA Application Pivotal Trial VEITH Symposium
BRÈVE

publiée le 19/11/2024 à 14:20, il y a 1 jour 20 heures

EnVVeno Medical demande l'approbation de la FDA pour VenoValve

EnVVeno Medical Insuffisance Veineuse Chronique Approbation De La FDA Valve VenoValve Demande De PMA
BRÈVE

publiée le 19/11/2024 à 14:20, il y a 1 jour 20 heures

EnVVeno Medical Seeks FDA Approval for VenoValve

FDA Approval EnVVeno Medical VenoValve Chronic Venous Insufficiency PMA Application
COMMUNIQUÉ DE PRESSE

publié le 19/11/2024 à 14:15, il y a 1 jour 20 heures

enVVeno Medical Submits the VenoValve PMA Application Seeking FDA Approval
enVVeno to present definitive one year data from PMA application at 51st VEITH Symposium. Company aims for FDA approval to market VenoValve in the US

FDA Approval VenoValve CVI PMA Application EnVVeno
BRÈVE

publiée le 31/10/2024 à 13:40, il y a 20 jours 21 heures

Résultats financiers du troisième trimestre 2024 d'enVVeno Medical et prochaines étapes de la FDA

Résultats Financiers Essais Cliniques Approbation De La FDA Valve VenoValve Progrès EnVVe
BRÈVE

publiée le 31/10/2024 à 13:40, il y a 20 jours 21 heures

EnVVeno Medical's Q3 2024 Financials and Upcoming FDA Milestones

Financial Results FDA Approval Clinical Trials VenoValve EnVVe Progress
COMMUNIQUÉ DE PRESSE

publié le 31/10/2024 à 13:35, il y a 20 jours 21 heures

enVVeno Medical Reports Third Quarter 2024 Financial Results and Confirms Guidance for Release of Definitive VenoValve Data in November and Completion of FDA Premarket Approval Application for VenoValve in Q4 of this Year
enVVeno Medical Corporation reports progress towards FDA PMA approval for VenoValve and enVVe transcatheter-based valve replacement. Company ends quarter with $48.4M cash

Financial Results VenoValve Clinical Program FDA PMA Approval EnVVe Transcatheter Valve
BRÈVE

publiée le 28/10/2024 à 13:35, il y a 23 jours 21 heures

EnVVeno Medical Commences Pre-Clinical Study for enVVe Valve

FDA Approval EnVVeno Medical CVI Treatment GLP Study EnVVe Valve

Les Echos

Publié le 21/11/2024 à 06:58, il y a 3 heures 43 minutes

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 3 heures 43 minutes

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 3 heures 43 minutes

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Publié le 20/11/2024 à 20:07, il y a 14 heures 33 minutes

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Publié le 20/11/2024 à 19:20, il y a 15 heures 21 minutes

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 21/11/2024 à 10:03, il y a 38 minutes

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Publié le 21/11/2024 à 10:00, il y a 41 minutes

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Publié le 21/11/2024 à 09:00, il y a 1 heure 41 minutes

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Publié le 21/11/2024 à 00:35, il y a 10 heures 6 minutes

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Publié le 21/11/2024 à 00:25, il y a 10 heures 16 minutes

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

Voir tout ACCESSWIRE

EQS Group

Publié le 21/11/2024 à 10:30, il y a 10 minutes

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Publié le 21/11/2024 à 10:04, il y a 36 minutes

Supervisory Board appoints Carsten Schmitt as new CFO
Publié le 21/11/2024 à 10:02, il y a 38 minutes

Supervisory Board appoints Carsten Schmitt as new CFO
Publié le 21/11/2024 à 10:00, il y a 40 minutes

Nabaltec AG continues solid earnings performance in third quarter of 2024
Publié le 21/11/2024 à 10:00, il y a 40 minutes

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV